Arbutus Biopharma Eulerpool Ziņas

Arbutus Biopharma Eulerpool News

Arbutus Biopharma Akciju Ziņas

Arbutus Biopharma tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Arbutus Biopharma ziņas mēs apkopojam šeit.

• 31. jūlijs ·

  Seeking Alpha
  Arbutus Biopharma Q2 2024 Earnings Preview
• 31. jūlijs ·

  Seeking Alpha
  Notable earnings before Thursday's open
• 23. jūlijs ·

  Seeking Alpha
  Amgen, Garmin among relative market leaders poised to outperform in coming months: BTIG
• 18. jūlijs ·

  Yahoo
  Arbutus to Report Second Quarter 2024 Financial Results and Provide Corporate Update
• 18. jūlijs ·

  TipRanks
  Arbutus Biopharma Sets Q2 2024 Financial Results Date
• 5. jūlijs ·

  SeekingAlpha
  Arbutus Biopharma: Focused On HBV With A Potentially Huge Litigation 'Wildcard'
• 5. jūlijs ·

  SeekingAlpha
  Arbutus Biopharma's IP Legal Wins And Clinical Trials - A Strong Buy Opportunity
• 13. jūnijs ·

  Yahoo
  Ultragenyx (RARE) Moves 7.8% Higher: Will This Strength Last?
• 10. jūnijs ·

  TipRanks
  Analysts Have Conflicting Sentiments on These Healthcare Companies: Halozyme (HALO), Arbutus Biopharma (ABUS) and Annexon Biosciences (ANNX)
• 6. jūnijs ·

  Yahoo
  Barinthus Bio's VTP-300 Trials Demonstrate Ability to Achieve Undetectable HBsAg levels and Statistical Significance in Lowering HBsAg Levels in People with Chronic Hepatitis B